Evidence map›Paper›PMID 39585329›Full record

ArticleeLife2024

The Jag2/Notch1 signaling axis promotes sebaceous gland differentiation and controls progenitor proliferation.

Syeda Nayab Fatima Abidi, Sara Chan, Kerstin Seidel, Daniel Lafkas, Louis Vermeulen, Frank Peale, Christian W Siebel

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Syeda Nayab Fatima AbidiDepartment of Discovery Oncology, Genentech, San Francisco, United States.ORCID https://orcid.org/0000-0002-3390-9363
Sara ChanDepartment of Research Pathology, Genentech, San Francisco, United States.
Kerstin SeidelDepartment of Discovery Oncology, Genentech, San Francisco, United States.
Daniel LafkasDepartment of Discovery Oncology, Genentech, San Francisco, United States.
Louis VermeulenDepartment of Discovery Oncology, Genentech, San Francisco, United States.
Frank PealeDepartment of Research Pathology, Genentech, San Francisco, United States.
Christian W SiebelDepartment of Discovery Oncology, Genentech, San Francisco, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sebaceous gland (SG) is a vital appendage of the epidermis, and its normal homeostasis and function is crucial for effective maintenance of the skin barrier. Notch signaling is a well-known regulator of epidermal differentiation, and has also been shown to be involved in postnatal maintenance of SGs. However, the precise role of Notch signaling in regulating SG differentiation in the adult homeostatic skin remains unclear. While there is evidence to suggest that Notch1 is the primary Notch receptor involved in regulating the differentiation process, the ligand remains unknown. Using monoclonal therapeutic antibodies designed to specifically inhibit of each of the Notch ligands or receptors, we have identified the Jag2/Notch1 signaling axis as the primary regulator of sebocyte differentiation in mouse homeostatic skin. Mature sebocytes are lost upon specific inhibition of the Jag2 ligand or Notch1 receptor, resulting in the accumulation of proliferative stem/progenitor cells in the SG. Strikingly, this phenotype is reversible, as these stem/progenitor cells re-enter differentiation when the inhibition of Notch activity is lifted. Thus, Notch activity promotes correct sebocyte differentiation, and is required to restrict progenitor proliferation.

Indexed as

Cell DifferentiationCell ProliferationJagged-2 ProteinReceptor, Notch1Sebaceous GlandsSignal TransductionStem CellsAnimalsMiceJag2 protein, mouseJagged-2 ProteinNotch1 protein, mouseReceptor, Notch1cell fatesdifferentiationmouseNotch signalingregenerative medicinestem cellstherapeutic antibodies

Identifiers

PMID39585329
PMCPMC11588336

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.